TABLE 7.
Mode of administration | Immune functiona | Reference(s) |
---|---|---|
In vivo | ||
Rats | ↓Antibody-forming cells | 66, 67 |
↓Intracellular Ca2+ stores | 101 | |
↓Lymphocyte proliferation | 218 | |
↑T-cell anergy | 67, 218 | |
↓Antimicrobial activity | 217 | |
In vitro | ||
Humans | ↓NK activity | 156 |
↓Cytokine production | 167 | |
Mice | ↓Splenocyte proliferation | 74, 75 |
↓↑Cytokine production | 74, 75, 136 | |
↓Antimicrobial activity | 136 |
↑, increase; ↓, decrease; ↑↓, both increase and decrease.